Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PhII ICb With/Without Erbitux in MBC Pts (CA225200)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2014 by US Oncology Research.
Recruitment status was  Active, not recruiting
Bristol-Myers Squibb
Information provided by (Responsible Party):
US Oncology Research Identifier:
First received: November 2, 2005
Last updated: May 19, 2014
Last verified: May 2014
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)